NeoGenomics (NEO) Surges 9.1%: Is This an Indication of Further Gains?

NeoGenomics (NEO) shares ended the last trading session 9.1% higher at $13.78. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 29.7% loss over the past four weeks.The stock price surged after NeoGenomics announced a multi-year exclusive strategic partnership with Adaptive Biotechnologies Corporation to enhance minimal residual disease (MRD) monitoring options for patients with certain blood cancers. Under the deal, ...